{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:02:25Z","timestamp":1774882945232,"version":"3.50.1"},"reference-count":211,"publisher":"Bentham Science Publishers Ltd.","issue":"36","funder":[{"DOI":"10.13039\/501100002923","name":"National Scientific and Technical Research Council","doi-asserted-by":"publisher","award":["PIP 2013-0664"],"award-info":[{"award-number":["PIP 2013-0664"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003033","name":"Ministry of Science, Technology and Productive Innovation, Argentina","doi-asserted-by":"publisher","award":["PICT 2013-0520"],"award-info":[{"award-number":["PICT 2013-0520"]}],"id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003033","name":"Ministry of Science, Technology and Productive Innovation, Argentina","doi-asserted-by":"publisher","award":["PIP 2013-0664"],"award-info":[{"award-number":["PIP 2013-0664"]}],"id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"National Agency for Science and Technology, Argentina","doi-asserted-by":"publisher","award":["PICT 2013-0520"],"award-info":[{"award-number":["PICT 2013-0520"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,12,13]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Chagas\u00b4 disease continues to be a challenging and neglected public health problem\nin many American countries. The etiologic agent, Trypanosoma cruzi, develops intracellularly\nin the mammalian host, which hinders treatment efficacy. Progress in the knowledge of parasite\nbiology and host-pathogen interaction has not been paralleled by the development of\nnovel, safe and effective therapeutic options. It is then urgent to seek for novel therapeutic\ncandidates and to implement drug discovery strategies that may accelerate the discovery process.\nThe most appealing targets for pharmacological intervention are those essential for the\npathogen and, whenever possible, absent or significantly different from the host homolog. The\nthiol-polyamine metabolism of T. cruzi offers interesting candidates for a rational design of\nselective drugs. In this respect, here we critically review the state of the art of the thiolpolyamine\nmetabolism of T. cruzi and the pharmacological potential of its components. On\nthe other hand, drug repurposing emerged as a valid strategy to identify new biological activities\nfor drugs in clinical use, while significantly shortening the long time and high cost associated\nwith de novo drug discovery approaches. Thus, we also discuss the different drug repurposing\nstrategies available with a special emphasis in their applications to the identification of\ndrug candidates targeting essential components of the thiol-polyamine metabolism of T. cruzi.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867325666180926151059","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T07:44:50Z","timestamp":1538034290000},"page":"6614-6635","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The Thiol-polyamine Metabolism of Trypanosoma cruzi: Molecular Targets and Drug Repurposing Strategies"],"prefix":"10.2174","volume":"26","author":[{"given":"Alan","family":"Talevi","sequence":"first","affiliation":[{"name":"Medicinal Chemistry, Department of Biological Sciences, Faculty of Exact Sciences, University of La Plata, La Plata, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Carrillo","sequence":"additional","affiliation":[{"name":"Instituto de Ciencias y Tecnolog\u00eda Dr. C\u00e9sar Milstein (ICT Milstein) - CONICET. Ciudad Aut\u00f3noma de Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Comini","sequence":"additional","affiliation":[{"name":"Institut Pasteur de Montevideo, Mataojo 2020, Montevideo 11400, Uruguay"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2017.50","volume":"4","author":"Browne A.J.","year":"2017","unstructured":"Browne A.J.; Guerra C.A.; Alves R.V.; da Costa V.M.; Wilson A.L.; Pigott D.M.; Hay S.I.; Lindsay S.W.; Golding N.; Moyes C.L.; The contemporary distribution of Trypanosoma cruzi infection in humans, alternative hosts and vectors. Sci Data 2017,4","journal-title":"Sci Data"},{"key":"ref=2","first-page":"33-44","volume":"90","year":"2015","unstructured":"Weekly epidemiological record - WHO World Health Organization. Chagas disease in latin america: an epidemiological update based on 2010 estimates2015,90(6),33-44","journal-title":"Weekly epidemiological record - WHO"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1038\/nature09221","volume":"465","author":"Coura J.R.","year":"2010","unstructured":"Coura J.R.; Vi\u00f1as P.A.; Chagas disease: a new worldwide challenge. Nature 2010,465(7301),S6-S7","journal-title":"Nature"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.resmic.2014.01.006","volume":"165","author":"Jimenez V.","year":"2014","unstructured":"Jimenez V.; Dealing with environmental challenges: mechanisms of adaptation in Trypanosoma cruzi. Res Microbiol 2014,165(3),155-165","journal-title":"Res Microbiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0065-308X(06)63002-9","volume":"63","author":"Barrett M.P.","year":"2006","unstructured":"Barrett M.P.; Gilbert I.H.; Targeting of toxic compounds to the trypanosome\u2019s interior. Adv Parasitol 2006,63,125-183","journal-title":"Adv Parasitol"},{"key":"ref=6","first-page":"43","author":"Pereira C.A.","year":"2013","unstructured":"Pereira C.A.; Carrillo C.;  In: Parasites: Ecology, Management and Diseases; Nova Science Publishers, I 2013,43-60","journal-title":"In: Parasites: Ecology, Management and Diseases; Nova Science Publishers, I"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","volume":"375","author":"Rassi A.","year":"2010","unstructured":"Rassi A.; Rassi A.; Marin-Neto J.A.; Chagas disease. Lancet 2010,375(9723),1388-1402","journal-title":"Lancet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1590\/0074-0276140362","volume":"110","author":"Coura J.R.","year":"2015","unstructured":"Coura J.R.; The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions--a comprehensive review. Mem Inst Oswaldo Cruz 2015,110(3),277-282","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.csbj.2016.12.002","volume":"15","author":"Chatelain E.","year":"2016","unstructured":"Chatelain E.; Chagas disease research and development: Is there light at the end of the tunnel? Comput Struct Biotechnol J 2016,15,98-103","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1128\/AAC.04660-14","volume":"59","author":"Molina I.","year":"2015","unstructured":"Molina I.; Salvador F.; S\u00e1nchez-Montalv\u00e1 A.; Trevi\u00f1o B.; Serre N.; Sao Avil\u00e9s A.; Almirante B.; Toxic profile of benznidazole in patients with chronic chagas disease: risk factors and comparison of the product from two different manufacturers. Antimicrob Agents Chemother 2015,59(10),6125-6131","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.4269\/ajtmh.15-0256","volume":"93","author":"Olivera M.J.","year":"2015","unstructured":"Olivera M.J.; Cucunub\u00e1 Z.M.; \u00c1lvarez C.A.; Nicholls R.S.; Safety profile of nifurtimox and treatment interruption for chronic chagas disease in colombian adults. Am J Trop Med Hyg 2015,93(6),1224-1230","journal-title":"Am J Trop Med Hyg"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","volume":"373","author":"Morillo C.A.","year":"2015","unstructured":"Morillo C.A.; Marin-Neto J.A.; Avezum A.; Sosa-Estani S.; Rassi A.; Rosas F.; Villena E.; Quiroz R.; Bonilla R.; Britto C.; Guhl F.; Velazquez E.; Bonilla L.; Meeks B.; Rao-Melacini P.; Pogue J.; Mattos A.; Lazdins J.; Rassi A.; Connolly S.J.; Yusuf S.; randomized trial of benznidazole for chronic chagas\u2019 cardiomyopathy. N Engl J Med BENEFIT investigators2015,373(14),1295-1306","journal-title":"N Engl J Med"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34039","volume":"7","author":"S\u00e1nchez-Vald\u00e9z F.J.","year":"2018","unstructured":"S\u00e1nchez-Vald\u00e9z F.J.; Padilla A.; Wang W.; Orr D.; Tarleton R.L.; Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure. eLife 2018,7","journal-title":"eLife"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1042\/bst0260606","volume":"26","author":"Ariyanayagam M.R.","year":"1998","unstructured":"Ariyanayagam M.R.; Tetaud E.; Fairlamb A.H.; Diamine auxotrophy in a eukaryotic parasite. Biochem Soc Trans 1998,26(4),606-609","journal-title":"Biochem Soc Trans"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/9783527670383.ch9","author":"Comini M.A.","year":"2013","unstructured":"Comini M.A.; Floh\u00e9 L.;  In: Trypanosomatids diseases, molecular routes to drug discovery 2013,167-199","journal-title":"In: Trypanosomatids diseases, molecular routes to drug discovery"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev.bi.45.070176.001441","volume":"45","author":"Tabor C.W.","year":"1976","unstructured":"Tabor C.W.; Tabor H.; 1,4-Diaminobutane (putrescine), spermidine, and spermine. Annu Rev Biochem 1976,45,285-306","journal-title":"Annu Rev Biochem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev.bi.53.070184.003533","volume":"53","author":"Tabor C.W.","year":"1984","unstructured":"Tabor C.W.; Tabor H.; Polyamines. Annu Rev Biochem 1984,53,749-790","journal-title":"Annu Rev Biochem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"14904","DOI":"10.1074\/jbc.R116.731661","volume":"291","author":"Pegg A.E.","year":"2016","unstructured":"Pegg A.E.; Functions of polyamines in mammals. J Biol Chem 2016,291(29),14904-14912","journal-title":"J Biol Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF01732046","volume":"16","author":"Goldemberg S.H.","year":"1977","unstructured":"Goldemberg S.H.; Algranati I.D.; Polyamines and protein synthesis: studies in various polyamine-requiring mutants of Escherichia coli. Mol Cell Biochem 1977,16(2),71-77","journal-title":"Mol Cell Biochem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1550-7408.1979.tb04658.x","volume":"26","author":"Bacchi C.J.","year":"1979","unstructured":"Bacchi C.J.; Vergara C.; Garofalo J.; Lipschik G.Y.; Hutner S.H.; Synthesis and content of polyamines in bloodstream Trypanosma brucei. J Protozool 1979,26(3),484-488","journal-title":"J Protozool"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1432-1033.1974.tb03790.x","volume":"48","author":"Igarashi K.","year":"1974","unstructured":"Igarashi K.; Sugawara K.; Izumi I.; Nagayama C.; Hirose S.; Effect of polyamines of polyphenylalanine synthesis by Escherichia coli and rat-liver ribosomes. Eur J Biochem 1974,48(2),495-502","journal-title":"Eur J Biochem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev.pa.35.040195.000415","volume":"35","author":"Marton L.J.","year":"1995","unstructured":"Marton L.J.; Pegg A.E.; Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995,35,55-91","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.4161\/auto.24709","volume":"9","author":"Vanrell M.C.","year":"2013","unstructured":"Vanrell M.C.; Cueto J.A.; Barclay J.J.; Carrillo C.; Colombo M.I.; Gottlieb R.A.; Romano P.S.; Polyamine depletion inhibits the autophagic response modulating Trypanosoma cruzi infectivity. Autophagy 2013,9(7),1080-1093","journal-title":"Autophagy"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1016\/j.jmb.2015.06.020","volume":"427","author":"Miller-Fleming L.","year":"2015","unstructured":"Miller-Fleming L.; Olin-Sandoval V.; Campbell K.; Ralser M.; Remaining mysteries of molecular biology: the role of polyamines in the cell. J Mol Biol 2015,427(21),3389-3406","journal-title":"J Mol Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11274-017-2370-y","volume":"33","author":"Gevrekci A.\u00d6.","year":"2017","unstructured":"Gevrekci A.\u00d6.; The roles of polyamines in microorganisms. World J Microbiol Biotechnol 2017,33(11),204","journal-title":"World J Microbiol Biotechnol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fchem.2018.00010","volume":"6","author":"Handa A.K.","year":"2018","unstructured":"Handa A.K.; Fatima T.; Mattoo A.K.; Polyamines: Bio-molecules with diverse functions in plant and human health and disease. Front Chem 2018,6,10","journal-title":"Front Chem"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1201\/9781351261760","author":"Floh\u00e9 L.","year":"2018","unstructured":"Floh\u00e9 L.;  Glutathione 2018","journal-title":"Glutathione"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1126\/science.3883489","volume":"227","author":"Fairlamb A.H.","year":"1985","unstructured":"Fairlamb A.H.; Blackburn P.; Ulrich P.; Chait B.T.; Cerami A.; Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science 1985,227(4693),1485-1487","journal-title":"Science"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1146\/annurev.mi.46.100192.003403","volume":"46","author":"Fairlamb A.H.","year":"1992","unstructured":"Fairlamb A.H.; Cerami A.; Metabolism and functions of trypanothione in the Kinetoplastida. Annu Rev Microbiol 1992,46,695-729","journal-title":"Annu Rev Microbiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1042\/bj1880643","volume":"188","author":"Boveris A.","year":"1980","unstructured":"Boveris A.; Sies H.; Martino E.E.; Docampo R.; Turrens J.F.; Stoppani A.O.; Deficient metabolic utilization of hydrogen peroxide in Trypanosoma cruzi. Biochem J 1980,188(3),643-648","journal-title":"Biochem J"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"13088","DOI":"10.1074\/jbc.M111.230847","volume":"286","author":"Hall B.S.","year":"2011","unstructured":"Hall B.S.; Bot C.; Wilkinson S.R.; Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites. J Biol Chem 2011,286(15),13088-13095","journal-title":"J Biol Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0166-6851(96)02837-X","volume":"86","author":"Maya J.D.","year":"1997","unstructured":"Maya J.D.; Repetto Y.; Agos\u00edn M.; Ojeda J.M.; Tellez R.; Gaule C.; Morello A.; Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi. Mol Biochem Parasitol 1997,86(1),101-106","journal-title":"Mol Biochem Parasitol"},{"key":"ref=33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002844","volume":"8","author":"Trochine A.","year":"2014","unstructured":"Trochine A.; Creek D.J.; Faral-Tello P.; Barrett M.P.; Robello C.; Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics. PLoS Negl Trop Dis 2014,8(5)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1073\/pnas.0711014105","volume":"105","author":"Wilkinson S.R.","year":"2008","unstructured":"Wilkinson S.R.; Taylor M.C.; Horn D.; Kelly J.M.; Cheeseman I.; A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proc Natl Acad Sci USA 2008,105(13),5022-5027","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1128\/AAC.01227-12","volume":"56","author":"Hall B.S.","year":"2012","unstructured":"Hall B.S.; Meredith E.L.; Wilkinson S.R.; Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs. Antimicrob Agents Chemother 2012,56(11),5821-5830","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"14407","DOI":"10.1038\/s41598-017-14986-6","volume":"7","author":"Campos M.C.","year":"2017","unstructured":"Campos M.C.; Phelan J.; Francisco A.F.; Taylor M.C.; Lewis M.D.; Pain A.; Clark T.G.; Kelly J.M.; Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole. Sci Rep 2017,7(1),14407","journal-title":"Sci Rep"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2018.10.436","volume":"130","author":"Mes\u00edas A.C.","year":"2019","unstructured":"Mes\u00edas A.C.; Sasoni N.; Arias D.G.; P\u00e9rez Brand\u00e1n C.; Orban O.C.F.; Kunick C.; Robello C.; Comini M.A.; Garg N.J.; Zago P.M.; Trypanothione synthetase confers growth, survival advantage, and resistance to anti-protozoal drugs in Trypanosoma cruzi. Free Radic Biol Med 2019,130,23-34","journal-title":"Free Radic Biol Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1128\/AAC.49.1.126-130.2005","volume":"49","author":"Faundez M.","year":"2005","unstructured":"Faundez M.; Pino L.; Letelier P.; Ortiz C.; L\u00f3pez R.; Seguel C.; Ferreira J.; Pavani M.; Morello A.; Maya J.D.; Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi. Antimicrob Agents Chemother 2005,49(1),126-130","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1128\/AAC.01454-07","volume":"52","author":"Fa\u00fandez M.","year":"2008","unstructured":"Fa\u00fandez M.; L\u00f3pez-Mu\u00f1oz R.; Torres G.; Morello A.; Ferreira J.; Kemmerling U.; Orellana M.; Maya J.D.; Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas\u2019 disease and enhances the efficacy of nifurtimox. Antimicrob Agents Chemother 2008,52(5),1837-1839","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1002\/1873-3468.12904","volume":"591","author":"V\u00e1zquez C.","year":"2017","unstructured":"V\u00e1zquez C.; Mejia-Tlachi M.; Gonz\u00e1lez-Ch\u00e1vez Z.; Silva A.; Rodr\u00edguez-Zavala J.S.; Moreno-S\u00e1nchez R.; Saavedra E.; Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi. FEBS Lett 2017,591(23),3881-3894","journal-title":"FEBS Lett"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"14529","DOI":"10.1074\/jbc.R500031200","volume":"281","author":"Pegg A.E.","year":"2006","unstructured":"Pegg A.E.; Regulation of ornithine decarboxylase. J Biol Chem 2006,281(21),14529-14532","journal-title":"J Biol Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/bse0460002","volume":"46","author":"Persson L.","year":"2009","unstructured":"Persson L.; Polyamine homoeostasis. Essays Biochem 2009,46,11-24","journal-title":"Essays Biochem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"14896","DOI":"10.1074\/jbc.R116.734780","volume":"291","author":"Michael A.J.","year":"2016","unstructured":"Michael A.J.; Polyamines in Eukaryotes, Bacteria, and Archaea. J Biol Chem 2016,291(29),14896-14903","journal-title":"J Biol Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fpls.2015.00827","volume":"6","author":"Liu J-H.","year":"2015","unstructured":"Liu J-H.; Wang W.; Wu H.; Gong X.; Moriguchi T.; Polyamines function in stress tolerance: from synthesis to regulation. Front Plant Sci 2015,6,827","journal-title":"Front Plant Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"E995","DOI":"10.1152\/ajpendo.90217.2008","volume":"294","author":"Pegg A.E.","year":"2008","unstructured":"Pegg A.E.; Spermidine\/spermine-N(1)-acetyltransferase: a key metabolic regulator. Am J Physiol Endocrinol Metab 2008,294(6),E995-E1010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/BJ20090598","volume":"421","author":"Casero R.A.","year":"2009","unstructured":"Casero R.A.; Pegg A.E.; Polyamine catabolism and disease. Biochem J 2009,421(3),323-338","journal-title":"Biochem J"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00726-011-1012-1","volume":"42","author":"Tavladoraki P.","year":"2012","unstructured":"Tavladoraki P.; Cona A.; Federico R.; Tempera G.; Viceconte N.; Saccoccio S.; Battaglia V.; Toninello A.; Agostinelli E.; Polyamine catabolism: target for antiproliferative therapies in animals and stress tolerance strategies in plants. Amino Acids 2012,42(2-3),411-426","journal-title":"Amino Acids"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/pcp\/pcu032","volume":"55","author":"Fujita M.","year":"2014","unstructured":"Fujita M.; Shinozaki K.; Identification of polyamine transporters in plants: paraquat transport provides crucial clues. Plant Cell Physiol 2014,55(5),855-861","journal-title":"Plant Cell Physiol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00726-013-1553-6","volume":"46","author":"Abdulhussein A.A.","year":"2014","unstructured":"Abdulhussein A.A.; Wallace H.M.; Polyamines and membrane transporters. Amino Acids 2014,46(3),655-660","journal-title":"Amino Acids"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.plaphy.2010.01.017","volume":"48","author":"Igarashi K.","year":"2010","unstructured":"Igarashi K.; Kashiwagi K.; Characteristics of cellular polyamine transport in prokaryotes and eukaryotes. Plant Physiol Biochem 2010,48(7),506-512","journal-title":"Plant Physiol Biochem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.6775372","volume":"210","author":"Bacchi C.J.","year":"1980","unstructured":"Bacchi C.J.; Nathan H.C.; Hutner S.H.; McCann P.P.; Sjoerdsma A.; Polyamine metabolism: a potential therapeutic target in trypanosomes. Science 1980,210(4467),332-334","journal-title":"Science"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0014-5793(99)00804-2","volume":"454","author":"Carrillo C.","year":"1999","unstructured":"Carrillo C.; Cejas S.; Gonz\u00e1lez N.S.; Algranati I.D.; Trypanosoma cruzi epimastigotes lack ornithine decarboxylase but can express a foreign gene encoding this enzyme. FEBS Lett 1999,454(3),192-196","journal-title":"FEBS Lett"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1550-7408.2003.tb00141.x","volume":"50","author":"Carrillo C.","year":"2003","unstructured":"Carrillo C.; Cejas S.; Huber A.; Gonz\u00e1lez N.S.; Algranati I.D.; Lack of arginine decarboxylase in Trypanosoma cruzi epimastigotes. J Eukaryot Microbiol 2003,50(5),312-316","journal-title":"J Eukaryot Microbiol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.bbrc.2006.03.215","volume":"344","author":"Carrillo C.","year":"2006","unstructured":"Carrillo C.; Canepa G.E.; Algranati I.D.; Pereira C.A.; Molecular and functional characterization of a spermidine transporter (TcPAT12) from Trypanosoma cruzi. Biochem Biophys Res Commun 2006,344(3),936-940","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1365-2958.2010.07081.x","volume":"76","author":"Hasne M-P.","year":"2010","unstructured":"Hasne M-P.; Coppens I.; Soysa R.; Ullman B.; A high-affinity putrescine-cadaverine transporter from Trypanosoma cruzi. Mol Microbiol 2010,76(1),78-91","journal-title":"Mol Microbiol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.bbrc.2004.07.002","volume":"321","author":"Bouvier L.A.","year":"2004","unstructured":"Bouvier L.A.; Silber A.M.; Galv\u00e3o Lopes C.; Canepa G.E.; Miranda M.R.; Tonelli R.R.; Colli W.; Alves M.J.M.; Pereira C.A.; Post genomic analysis of permeases from the amino acid\/auxin family in protozoan parasites. Biochem Biophys Res Commun 2004,321(3),547-556","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0005-2736(98)00196-5","volume":"1415","author":"Young G.","year":"1999","unstructured":"Young G.; Jack D.; Smith D.; Saier M.; The amino acid\/auxin: proton symport permease family. biochimica et biophysica acta (BBA) -. Biomembranes 1999,1415(2),306-322","journal-title":"Biomembranes"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1042\/BJ20071185","volume":"409","author":"Taylor M.C.","year":"2008","unstructured":"Taylor M.C.; Kaur H.; Blessington B.; Kelly J.M.; Wilkinson S.R.; Validation of spermidine synthase as a drug target in African trypanosomes. Biochem J 2008,409(2),563-569","journal-title":"Biochem J"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1128\/IAI.00073-11","volume":"79","author":"Gilroy C.","year":"2011","unstructured":"Gilroy C.; Olenyik T.; Roberts S.C.; Ullman B.; Spermidine synthase is required for virulence of Leishmania donovani. Infect Immun 2011,79(7),2764-2769","journal-title":"Infect Immun"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.1038\/s41598-017-06411-9","volume":"7","author":"Yoshino R.","year":"2017","unstructured":"Yoshino R.; Yasuo N.; Hagiwara Y.; Ishida T.; Inaoka D.K.; Amano Y.; Tateishi Y.; Ohno K.; Namatame I.; Niimi T.; Orita M.; Kita K.; Akiyama Y.; Sekijima M.; In silico, in vitro, X-ray crystallography, and integrated strategies for discovering spermidine synthase inhibitors for Chagas disease. Sci Rep 2017,7(1),6666","journal-title":"Sci Rep"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1021\/acs.jmedchem.5b01769","volume":"59","author":"Yamasaki K.","year":"2016","unstructured":"Yamasaki K.; Tani O.; Tateishi Y.; Tanabe E.; Namatame I.; Niimi T.; Furukawa K.; Sakashita H.; An NMR biochemical assay for fragment-based drug discovery: evaluation of an inhibitor activity on spermidine synthase of trypanosoma cruzi. J Med Chem 2016,59(5),2261-2266","journal-title":"J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1107\/S1399004715013048","volume":"71","author":"Amano Y.","year":"2015","unstructured":"Amano Y.; Namatame I.; Tateishi Y.; Honboh K.; Tanabe E.; Niimi T.; Sakashita H.; Structural insights into the novel inhibition mechanism of Trypanosoma cruzi spermidine synthase. Acta Crystallogr D Biol Crystallogr 2015,71(Pt 9),1879-1889","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1111\/j.1742-4658.2012.08557.x","volume":"279","author":"Olin-Sandoval V.","year":"2012","unstructured":"Olin-Sandoval V.; Gonz\u00e1lez-Ch\u00e1vez Z.; Berzunza-Cruz M.; Mart\u00ednez I.; Jasso-Ch\u00e1vez R.; Becker I.; Espinoza B.; Moreno-S\u00e1nchez R.; Saavedra E.; Drug target validation of the trypanothione pathway enzymes through metabolic modelling. FEBS J 2012,279(10),1811-1833","journal-title":"FEBS J"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.1112631","volume":"309","author":"El-Sayed N.M.","year":"2005","unstructured":"El-Sayed N.M.; Myler P.J.; Bartholomeu D.C.; Nilsson D.; Aggarwal G.; Tran A.N.; Ghedin E.; Worthey E.A.; Delcher A.L.; Blandin G.; Westenberger S.J.; Caler E.; Cerqueira G.C.; Branche C.; Haas B.; Anupama A.; Arner E.; Aslund L.; Attipoe P.; Bontempi E.; Bringaud F.; Burton P.; Cadag E.; Campbell D.A.; Carrington M.; Crabtree J.; Darban H.; da Silveira J.F.; de Jong P.; Edwards K.; Englund P.T.; Fazelina G.; Feldblyum T.; Ferella M.; Frasch A.C.; Gull K.; Horn D.; Hou L.; Huang Y.; Kindlund E.; Klingbeil M.; Kluge S.; Koo H.; Lacerda D.; Levin M.J.; Lorenzi H.; Louie T.; Machado C.R.; McCulloch R.; McKenna A.; Mizuno Y.; Mottram J.C.; Nelson S.; Ochaya S.; Osoegawa K.; Pai G.; Parsons M.; Pentony M.; Pettersson U.; Pop M.; Ramirez J.L.; Rinta J.; Robertson L.; Salzberg S.L.; Sanchez D.O.; Seyler A.; Sharma R.; Shetty J.; Simpson A.J.; Sisk E.; Tammi M.T.; Tarleton R.; Teixeira S.; Van Aken S.; Vogt C.; Ward P.N.; Wickstead B.; Wortman J.; White O.; Fraser C.M.; Stuart K.D.; Andersson B.; The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005,309(5733),409-415","journal-title":"Science"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/ars.2017.7133","volume":"28","author":"Manta B.","year":"2018","unstructured":"Manta B.; Bonilla M.; Fiestas L.; Sturlese M.; Salinas G.; Bellanda M.; Comini M.A.; Polyamine-based thiols in trypanosomatids: evolution, protein structural adaptations, and biological functions. Antioxid Redox Signal 2018,28(6),463-486","journal-title":"Antioxid Redox Signal"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"35853","DOI":"10.1074\/jbc.M204403200","volume":"277","author":"Oza S.L.","year":"2002","unstructured":"Oza S.L.; Tetaud E.; Ariyanayagam M.R.; Warnon S.S.; Fairlamb A.H.; A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi. J Biol Chem 2002,277(39),35853-35861","journal-title":"J Biol Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1201\/9781351261760-17","author":"Comini M.A.","year":"2018","unstructured":"Comini M.A.;  In: Glutathione 2018,285-305","journal-title":"In: Glutathione"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.freeradbiomed.2004.02.008","volume":"36","author":"Comini M.A.","year":"2004","unstructured":"Comini M.A.; Guerrero S.A.; Haile S.; Menge U.; L\u00fcnsdorf H.; Floh\u00e9 L.; Validation of Trypanosoma brucei trypanothione synthetase as drug target. Free Radic Biol Med 2004,36(10),1289-1302","journal-title":"Free Radic Biol Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.freeradbiomed.2014.05.007","volume":"73","author":"Sousa A.F.","year":"2014","unstructured":"Sousa A.F.; Gomes-Alves A.G.; Ben\u00edtez D.; Comini M.A.; Floh\u00e9 L.; Jaeger T.; Passos J.; Stuhlmann F.; Tom\u00e1s A.M.; Castro H.; Genetic and chemical analyses reveal that trypanothione synthetase but not glutathionylspermidine synthetase is essential for Leishmania infantum. Free Radic Biol Med 2014,73,229-238","journal-title":"Free Radic Biol Med"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1074\/jbc.274.6.3781","volume":"274","author":"Jiang Y.","year":"1999","unstructured":"Jiang Y.; Roberts S.C.; Jardim A.; Carter N.S.; Shih S.; Ariyanayagam M.; Fairlamb A.H.; Ullman B.; Ornithine decarboxylase gene deletion mutants of Leishmania donovani. J Biol Chem 1999,274(6),3781-3788","journal-title":"J Biol Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/EC.00047-09","volume":"8","author":"Xiao Y.","year":"2009","unstructured":"Xiao Y.; McCloskey D.E.; Phillips M.A.; RNA interference-mediated silencing of ornithine decarboxylase and spermidine synthase genes in Trypanosoma brucei provides insight into regulation of polyamine biosynthesis. Eukaryot Cell 2009,8(5),747-755","journal-title":"Eukaryot Cell"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1432-1033.1989.tb14643.x","volume":"180","author":"Jockers-Scher\u00fcbl M.C.","year":"1989","unstructured":"Jockers-Scher\u00fcbl M.C.; Schirmer R.H.; Krauth-Siegel R.L.; Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds. Eur J Biochem 1989,180(2),267-272","journal-title":"Eur J Biochem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1046\/j.1365-2958.2000.01721.x","volume":"35","author":"Krieger S.","year":"2000","unstructured":"Krieger S.; Schwarz W.; Ariyanayagam M.R.; Fairlamb A.H.; Krauth-Siegel R.L.; Clayton C.; Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress. Mol Microbiol 2000,35(3),542-552","journal-title":"Mol Microbiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1093\/emboj\/16.10.2590","volume":"16","author":"Dumas C.","year":"1997","unstructured":"Dumas C.; Ouellette M.; Tovar J.; Cunningham M.L.; Fairlamb A.H.; Tamar S.; Olivier M.; Papadopoulou B.; Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages. EMBO J 1997,16(10),2590-2598","journal-title":"EMBO J"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1042\/bj3300951","volume":"330","author":"Barderi P.","year":"1998","unstructured":"Barderi P.; Campetella O.; Frasch A.C.; Santom\u00e9 J.A.; Hellman U.; Pettersson U.; Cazzulo J.J.; The NADP+-linked glutamate dehydrogenase from Trypanosoma cruzi: sequence, genomic organization and expression. Biochem J 1998,330(Pt 2),951-958","journal-title":"Biochem J"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1574-6968.2004.tb09522.x","volume":"234","author":"Maugeri D.A.","year":"2004","unstructured":"Maugeri D.A.; Cazzulo J.J.; The pentose phosphate pathway in Trypanosoma cruzi. FEMS Microbiol Lett 2004,234(1),117-123","journal-title":"FEMS Microbiol Lett"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.molbiopara.2011.01.010","volume":"177","author":"Leroux A.E.","year":"2011","unstructured":"Leroux A.E.; Maugeri D.A.; Cazzulo J.J.; Nowicki C.; Functional characterization of NADP-dependent isocitrate dehydrogenase isozymes from Trypanosoma cruzi. Mol Biochem Parasitol 2011,177(1),61-64","journal-title":"Mol Biochem Parasitol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1574-6968.2010.02142.x","volume":"314","author":"Leroux A.E.","year":"2011","unstructured":"Leroux A.E.; Maugeri D.A.; Opperdoes F.R.; Cazzulo J.J.; Nowicki C.; Comparative studies on the biochemical properties of the malic enzymes from Trypanosoma cruzi and Trypanosoma brucei. FEMS Microbiol Lett 2011,314(1),25-33","journal-title":"FEMS Microbiol Lett"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"p. 297\u2013313","DOI":"10.1002\/9783527670383.ch16","author":"Comini M.A.","year":"2013","unstructured":"Comini M.A.; Ort\u00edz C.; Cazzulo J.J.; Drug targets in trypanosomal\nand leishmanial pentose phosphate pathway. In: Trypanosomatid Diseases; Molecular routes to drug discovery Ed. J\u00e4ger T, Koch O, Floh\u00e9 L. Wiley-VCH Verlag GmbH","journal-title":"Trypanosomatid Diseases; Molecular routes to drug discovery"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.pt.2016.04.010","volume":"32","author":"Kov\u00e1\u0159ov\u00e1 J.","year":"2016","unstructured":"Kov\u00e1\u0159ov\u00e1 J.; Barrett M.P.; The Pentose Phosphate Pathway in Parasitic Trypanosomatids. Trends Parasitol 2016,32(8),622-634","journal-title":"Trends Parasitol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.bbagen.2008.03.006","volume":"1780","author":"Krauth-Siegel R.L.","year":"2008","unstructured":"Krauth-Siegel R.L.; Comini M.A.; Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism. Biochim Biophys Acta 2008,1780(11),1236-1248","journal-title":"Biochim Biophys Acta"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1016\/j.bbagen.2013.01.013","volume":"1830","author":"Manta B.","year":"2013","unstructured":"Manta B.; Comini M.; Medeiros A.; Hugo M.; Trujillo M.; Radi R.; Trypanothione: a unique bis-glutathionyl derivative in trypanosomatids. Biochim Biophys Acta 2013,1830(5),3199-3216","journal-title":"Biochim Biophys Acta"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pt.2011.11.001","volume":"28","author":"Willert E.","year":"2012","unstructured":"Willert E.; Phillips M.A.; Regulation and function of polyamines in African trypanosomes. Trends Parasitol 2012,28(2),66-72","journal-title":"Trends Parasitol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1096\/fj.09-146407","volume":"24","author":"Bocedi A.","year":"2010","unstructured":"Bocedi A.; Dawood K.F.; Fabrini R.; Federici G.; Gradoni L.; Pedersen J.Z.; Ricci G.; Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites. FASEB J 2010,24(4),1035-1042","journal-title":"FASEB J"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1089\/ars.2012.4859","volume":"19","author":"Manta B.","year":"2013","unstructured":"Manta B.; Pavan C.; Sturlese M.; Berndt C.; Krauth-Siegel R.L.; Bellanda M.; Comini M.A.; Biochemical and structural basis for iron-sulfur cluster coordination by mitochondrial monothiol glutaredoxin-1 of Trypanosoma brucei. Antioxid Redox Signal 2013,19,665-682","journal-title":"Antioxid Redox Signal"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0006-2952(02)01663-5","volume":"65","author":"Maya J.D.","year":"2003","unstructured":"Maya J.D.; Bollo S.; Nu\u00f1ez-Vergara L.J.; Squella J.A.; Repetto Y.; Morello A.; P\u00e9ri\u00e9 J.; Chauvi\u00e8re G.; Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives. Biochem Pharmacol 2003,65(6),999-1006","journal-title":"Biochem Pharmacol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cbpa.2006.03.004","volume":"146","author":"Maya J.D.","year":"2007","unstructured":"Maya J.D.; Cassels B.K.; Iturriaga-V\u00e1squez P.; Ferreira J.; Fa\u00fandez M.; Galanti N.; Ferreira A.; Morello A.; Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comp Biochem Physiol A Mol Integr Physiol 2007,146(4),601-620","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0305-0491(96)00112-5","volume":"115","author":"Repetto Y.","year":"1996","unstructured":"Repetto Y.; Opazo E.; Maya J.D.; Agosin M.; Morello A.; Glutathione and trypanothione in several strains of Trypanosoma cruzi: effect of drugs. Comp Biochem Physiol B Biochem Mol Biol 1996,115(2),281-285","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/BJ20060882","volume":"400","author":"Greig N.","year":"2006","unstructured":"Greig N.; Wyllie S.; Vickers T.J.; Fairlamb A.H.; Trypanothione-dependent glyoxalase I in Trypanosoma cruzi. Biochem J 2006,400(2),217-223","journal-title":"Biochem J"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1742-4658.2008.06788.x","volume":"276","author":"Greig N.","year":"2009","unstructured":"Greig N.; Wyllie S.; Patterson S.; Fairlamb A.H.; A comparative study of methylglyoxal metabolism in trypanosomatids. FEBS J 2009,276(2),376-386","journal-title":"FEBS J"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ijmm.2012.07.005","volume":"302","author":"Sousa Silva M.","year":"2012","unstructured":"Sousa Silva M.; Ferreira A.E.; Gomes R.; Tom\u00e1s A.M.; Ponces Freire A.; Cordeiro C.; The glyoxalase pathway in protozoan parasites. Int J Med Microbiol 2012,302(4-5),225-229","journal-title":"Int J Med Microbiol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/09553009214552281","volume":"62","author":"Awad S.","year":"1992","unstructured":"Awad S.; Henderson G.B.; Cerami A.; Held K.D.; Effects of trypanothione on the biological activity of irradiated transforming DNA. Int J Radiat Biol 1992,62(4),401-407","journal-title":"Int J Radiat Biol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.freeradbiomed.2013.04.036","volume":"63","author":"Arias D.G.","year":"2013","unstructured":"Arias D.G.; Marquez V.E.; Chiribao M.L.; Gadelha F.R.; Robello C.; Iglesias A.A.; Guerrero S.A.; Redox metabolism in Trypanosoma cruzi: functional characterization of tryparedoxins revisited. Free Radic Biol Med 2013,63,65-77","journal-title":"Free Radic Biol Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jprot.2015.03.001","volume":"120","author":"Arias D.G.","year":"2015","unstructured":"Arias D.G.; Pi\u00f1eyro M.D.; Iglesias A.A.; Guerrero S.A.; Robello C.; Molecular characterization and interactome analysis of Trypanosoma cruzi tryparedoxin II. J Proteomics 2015,120,95-104","journal-title":"J Proteomics"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biochi.2014.07.027","volume":"106","author":"M\u00e1rquez V.E.","year":"2014","unstructured":"M\u00e1rquez V.E.; Arias D.G.; Chiribao M.L.; Faral-Tello P.; Robello C.; Iglesias A.A.; Guerrero S.A.; Redox metabolism in Trypanosoma cruzi. Biochemical characterization of dithiol glutaredoxin dependent cellular pathways. Biochimie 2014,106,56-67","journal-title":"Biochimie"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.actatropica.2005.10.005","volume":"97","author":"Piattoni C.V.","year":"2006","unstructured":"Piattoni C.V.; Blancato V.S.; Miglietta H.; Iglesias A.A.; Guerrero S.A.; On the occurrence of thioredoxin in Trypanosoma cruzi. Acta Trop 2006,97(2),151-160","journal-title":"Acta Trop"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0166-6851(02)00215-3","volume":"125","author":"Schmidt A.","year":"2002","unstructured":"Schmidt A.; Clayton C.E.; Krauth-Siegel R.L.; Silencing of the thioredoxin gene in Trypanosoma brucei brucei. Mol Biochem Parasitol 2002,125(1-2),207-210","journal-title":"Mol Biochem Parasitol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1089\/ars.2009.2907","volume":"12","author":"Marquez V.E.","year":"2010","unstructured":"Marquez V.E.; Arias D.G.; Piattoni C.V.; Robello C.; Iglesias A.A.; Guerrero S.A.; Cloning, expression, and characterization of a dithiol glutaredoxin from Trypanosoma cruzi. Antioxid Redox Signal 2010,12(6),787-792","journal-title":"Antioxid Redox Signal"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jprot.2011.04.006","volume":"74","author":"Pi\u00f1eyro M.D.","year":"2011","unstructured":"Pi\u00f1eyro M.D.; Parodi-Talice A.; Portela M.; Arias D.G.; Guerrero S.A.; Robello C.; Molecular characterization and interactome analysis of Trypanosoma cruzi tryparedoxin 1. J Proteomics 2011,74(9),1683-1692","journal-title":"J Proteomics"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00232-016-9888-z","volume":"249","author":"Reigada C.","year":"2016","unstructured":"Reigada C.; Say\u00e9 M.; Vera E.V.; Balcazar D.; Fraccaroli L.; Carrillo C.; Miranda M.R.; Pereira C.A.; Trypanosoma cruzi polyamine transporter: its role on parasite growth and survival under stress conditions. J Membr Biol 2016,249(4),475-481","journal-title":"J Membr Biol"},{"key":"ref=101","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/657460","volume":"2011","author":"Barclay J.J.","year":"2011","unstructured":"Barclay J.J.; Morosi L.G.; Vanrell M.C.; Trejo E.C.; Romano P.S.; Carrillo C.; Trypanosoma cruzi coexpressing ornithine decarboxylase and green fluorescence proteins as a tool to study the role of polyamines in chagas disease pathology. Enzyme Res 2011,2011","journal-title":"Enzyme Res"},{"key":"ref=102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006049","volume":"11","author":"Vanrell M.C.","year":"2017","unstructured":"Vanrell M.C.; Losinno A.D.; Cueto J.A.; Balcazar D.; Fraccaroli L.V.; Carrillo C.; Romano P.S.; The regulation of autophagy differentially affects Trypanosoma cruzi metacyclogenesis. PLoS Negl Trop Dis 2017,11(11)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152715","volume":"11","author":"Hasne M-P.","year":"2016","unstructured":"Hasne M-P.; Soysa R.; Ullman B.; The trypanosoma cruzi diamine transporter is essential for robust infection of mammalian cells. PLoS One 2016,11(4)","journal-title":"PLoS One"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1574-6968.2010.01936.x","volume":"306","author":"Carrillo C.","year":"2010","unstructured":"Carrillo C.; Canepa G.E.; Giacometti A.; Bouvier L.A.; Miranda M.R.; de los Milagros Camara M.; Pereira C.A.; Trypanosoma cruzi amino acid transporter TcAAAP411 mediates arginine uptake in yeasts. FEMS Microbiol Lett 2010,306(2),97-102","journal-title":"FEMS Microbiol Lett"},{"key":"ref=105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032760","volume":"7","author":"Miranda M.R.","year":"2012","unstructured":"Miranda M.R.; Say\u00e9 M.; Bouvier L.A.; C\u00e1mara, Mde.L.; Montserrat, J.; Pereira, C.A. Cationic amino acid uptake constitutes a metabolic regulation mechanism and occurs in the flagellar pocket of Trypanosoma cruzi. PLoS One 2012,7(2)","journal-title":"PLoS One"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00726-010-0812-z","volume":"42","author":"Inbar E.","year":"2012","unstructured":"Inbar E.; Canepa G.E.; Carrillo C.; Glaser F.; Suter Grotemeyer M.; Rentsch D.; Zilberstein D.; Pereira C.A.; Lysine transporters in human trypanosomatid pathogens. Amino Acids 2012,42(1),347-360","journal-title":"Amino Acids"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"7339","DOI":"10.1021\/jm9004835","volume":"52","author":"Cavalli A.","year":"2009","unstructured":"Cavalli A.; Bolognesi M.L.; Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania. J Med Chem 2009,52(23),7339-7359","journal-title":"J Med Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0166-6851(96)02788-0","volume":"84","author":"Ariyanayagam M.R.","year":"1997","unstructured":"Ariyanayagam M.R.; Fairlamb A.H.; Diamine auxotrophy may be a universal feature of Trypanosoma cruzi epimastigotes. Mol Biochem Parasitol 1997,84(1),111-121","journal-title":"Mol Biochem Parasitol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbagen.2014.10.029","volume":"1850","author":"Gonz\u00e1lez-Ch\u00e1vez Z.","year":"2015","unstructured":"Gonz\u00e1lez-Ch\u00e1vez Z.; Olin-Sandoval V.; Rod\u00edguez-Zavala J.S.; Moreno-S\u00e1nchez R.; Saavedra E.; Metabolic control analysis of the Trypanosoma cruzi peroxide detoxification pathway identifies tryparedoxin as a suitable drug target. Biochim Biophys Acta 2015,1850(2),263-273","journal-title":"Biochim Biophys Acta"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"39794","DOI":"10.1074\/jbc.M306306200","volume":"278","author":"Huynh T.T.","year":"2003","unstructured":"Huynh T.T.; Huynh V.T.; Harmon M.A.; Phillips M.A.; Gene knockdown of gamma-glutamylcysteine synthetase by RNAi in the parasitic protozoa Trypanosoma brucei demonstrates that it is an essential enzyme. J Biol Chem 2003,278(41),39794-39800","journal-title":"J Biol Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1042\/BJ20061341","volume":"402","author":"Comini M.A.","year":"2007","unstructured":"Comini M.A.; Krauth-Siegel R.L.; Floh\u00e9 L.; Depletion of the thioredoxin homologue tryparedoxin impairs antioxidative defence in African trypanosomes. Biochem J 2007,402(1),43-49","journal-title":"Biochem J"},{"key":"ref=112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004617","volume":"10","author":"Ben\u00edtez D.","year":"2016","unstructured":"Ben\u00edtez D.; Medeiros A.; Fiestas L.; Panozzo-Zenere E.A.; Maiwald F.; Prousis K.C.; Roussaki M.; Calogeropoulou T.; Detsi A.; Jaeger T.; \u0160arlauskas J.; Peterlin Ma\u0161i\u010d L.; Kunick C.; Labadie G.R.; Floh\u00e9 L.; Comini M.A.; Identification of novel chemical scaffolds inhibiting trypanothione synthetase from pathogenic trypanosomatids. PLoS Negl Trop Dis 2016,10(4)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1016\/j.bmc.2016.06.023","volume":"24","author":"Orban O.C.","year":"2016","unstructured":"Orban O.C.; Korn R.S.; Ben\u00edtez D.; Medeiros A.; Preu L.; Loa\u00ebc N.; Meijer L.; Koch O.; Comini M.A.; Kunick C.; 5-Substituted 3-chlorokenpaullone derivatives are potent inhibitors of Trypanosoma brucei bloodstream forms. Bioorg Med Chem 2016,24(16),3790-3800","journal-title":"Bioorg Med Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"17485","DOI":"10.1074\/jbc.271.29.17485","volume":"271","author":"Lueder D.V.","year":"1996","unstructured":"Lueder D.V.; Phillips M.A.; Characterization of Trypanosoma brucei gamma-glutamylcysteine synthetase, an essential enzyme in the biosynthesis of trypanothione (diglutathionylspermidine). J Biol Chem 1996,271(29),17485-17490","journal-title":"J Biol Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1515\/BC.2001.056","volume":"382","author":"Hofmann B.","year":"2001","unstructured":"Hofmann B.; Budde H.; Bruns K.; Guerrero S.A.; Kalisz H.M.; Menge U.; Montemartini M.; Nogoceke E.; Steinert P.; Wissing J.B.; Floh\u00e9 L.; Hecht H.J.; Structures of tryparedoxins revealing interaction with trypanothione. Biol Chem 2001,382(3),459-471","journal-title":"Biol Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"8792","DOI":"10.1074\/jbc.M111.338285","volume":"287","author":"Fueller F.","year":"2012","unstructured":"Fueller F.; Jehle B.; Putzker K.; Lewis J.D.; Krauth-Siegel R.L.; High throughput screening against the peroxidase cascade of African trypanosomes identifies antiparasitic compounds that inactivate tryparedoxin. J Biol Chem 2012,287(12),8792-8802","journal-title":"J Biol Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molbiopara.2015.11.003","volume":"206","author":"Leroux A.E.","year":"2016","unstructured":"Leroux A.E.; Krauth-Siegel R.L.; Thiol redox biology of trypanosomatids and potential targets for chemotherapy. Mol Biochem Parasitol 2016,206(1-2),67-74","journal-title":"Mol Biochem Parasitol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1432-1033.1987.tb11002.x","volume":"164","author":"Krauth-Siegel R.L.","year":"1987","unstructured":"Krauth-Siegel R.L.; Enders B.; Henderson G.B.; Fairlamb A.H.; Schirmer R.H.; Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme. Eur J Biochem 1987,164(1),123-128","journal-title":"Eur J Biochem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0969-2126(99)80011-2","volume":"7","author":"Bond C.S.","year":"1999","unstructured":"Bond C.S.; Zhang Y.; Berriman M.; Cunningham M.L.; Fairlamb A.H.; Hunter W.N.; Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors. Structure 1999,7(1),81-89","journal-title":"Structure"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/pro.5560050107","volume":"5","author":"Zhang Y.","year":"1996","unstructured":"Zhang Y.; Bond C.S.; Bailey S.; Cunningham M.L.; Fairlamb A.H.; Hunter W.N.; The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 a resolution. Protein Sci 1996,5(1),52-61","journal-title":"Protein Sci"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"29493","DOI":"10.1074\/jbc.M403187200","volume":"279","author":"Saravanamuthu A.","year":"2004","unstructured":"Saravanamuthu A.; Vickers T.J.; Bond C.S.; Peterson M.R.; Hunter W.N.; Fairlamb A.H.; Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design. J Biol Chem 2004,279(28),29493-29500","journal-title":"J Biol Chem"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"17672","DOI":"10.1074\/jbc.M801850200","volume":"283","author":"Fyfe P.K.","year":"2008","unstructured":"Fyfe P.K.; Oza S.L.; Fairlamb A.H.; Hunter W.N.; Leishmania trypanothione synthetase-amidase structure reveals a basis for regulation of conflicting synthetic and hydrolytic activities. J Biol Chem 2008,283(25),17672-17680","journal-title":"J Biol Chem"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"36137","DOI":"10.1074\/jbc.M109.045336","volume":"284","author":"Torrie L.S.","year":"2009","unstructured":"Torrie L.S.; Wyllie S.; Spinks D.; Oza S.L.; Thompson S.; Harrison J.R.; Gilbert I.H.; Wyatt P.G.; Fairlamb A.H.; Frearson J.A.; Chemical validation of trypanothione synthetase: a potential drug target for human trypanosomiasis. J Biol Chem 2009,284(52),36137-36145","journal-title":"J Biol Chem"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/cmdc.201100420","volume":"7","author":"Spinks D.","year":"2012","unstructured":"Spinks D.; Torrie L.S.; Thompson S.; Harrison J.R.; Frearson J.A.; Read K.D.; Fairlamb A.H.; Wyatt P.G.; Gilbert I.H.; Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors. ChemMedChem 2012,7(1),95-106","journal-title":"ChemMedChem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1111\/j.1742-4658.2008.06670.x","volume":"275","author":"Oza S.L.","year":"2008","unstructured":"Oza S.L.; Chen S.; Wyllie S.; Coward J.K.; Fairlamb A.H.; ATP-dependent ligases in trypanothione biosynthesis--kinetics of catalysis and inhibition by phosphinic acid pseudopeptides. FEBS J 2008,275(21),5408-5421","journal-title":"FEBS J"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1021\/jm990259w","volume":"43","author":"D\u2019Silva C.","year":"2000","unstructured":"D\u2019Silva C.; Daunes S.; Structure-activity study on the in vitro antiprotozoal activity of glutathione derivatives. J Med Chem 2000,43(10),2072-2078","journal-title":"J Med Chem"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1021\/jm050922i","volume":"49","author":"Ravaschino E.L.","year":"2006","unstructured":"Ravaschino E.L.; Docampo R.; Rodriguez J.B.; Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis. J Med Chem 2006,49(1),426-435","journal-title":"J Med Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1089\/ars.2008.2050","volume":"10","author":"Castro H.","year":"2008","unstructured":"Castro H.; Tom\u00e1s A.M.; Peroxidases of trypanosomatids. Antioxid Redox Signal 2008,10(9),1593-1606","journal-title":"Antioxid Redox Signal"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1042\/bj20020038","volume":"364","author":"Wilkinson S.R.","year":"2002","unstructured":"Wilkinson S.R.; Taylor M.C.; Touitha S.; Mauricio I.L.; Meyer D.J.; Kelly J.M.; TcGPXII, a glutathione-dependent Trypanosoma cruzi peroxidase with substrate specificity restricted to fatty acid and phospholipid hydroperoxides, is localized to the endoplasmic reticulum. Biochem J 2002,364(Pt 3),787-794","journal-title":"Biochem J"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"8220","DOI":"10.1074\/jbc.275.11.8220","volume":"275","author":"Wilkinson S.R.","year":"2000","unstructured":"Wilkinson S.R.; Temperton N.J.; Mondragon A.; Kelly J.M.; Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi. J Biol Chem 2000,275(11),8220-8225","journal-title":"J Biol Chem"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1042\/bj3520755","volume":"352","author":"Wilkinson S.R.","year":"2000","unstructured":"Wilkinson S.R.; Meyer D.J.; Kelly J.M.; Biochemical characterization of a trypanosome enzyme with glutathione-dependent peroxidase activity. Biochem J 2000,352(Pt 3),755-761","journal-title":"Biochem J"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/BJ20071138","volume":"410","author":"Piacenza L.","year":"2008","unstructured":"Piacenza L.; Peluffo G.; Alvarez M.N.; Kelly J.M.; Wilkinson S.R.; Radi R.; Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite. Biochem J 2008,410(2),359-368","journal-title":"Biochem J"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gene.2007.10.014","volume":"408","author":"Pi\u00f1eyro M.D.","year":"2008","unstructured":"Pi\u00f1eyro M.D.; Parodi-Talice A.; Arcari T.; Robello C.; Peroxiredoxins from Trypanosoma cruzi: virulence factors and drug targets for treatment of Chagas disease? Gene 2008,408(1-2),45-50","journal-title":"Gene"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molbiopara.2016.03.005","volume":"206","author":"Angelucci F.","year":"2016","unstructured":"Angelucci F.; Miele A.E.; Ardini M.; Boumis G.; Saccoccia F.; Bellelli A.; Typical 2-Cys peroxiredoxins in human parasites: Several physiological roles for a potential chemotherapy target. Mol Biochem Parasitol 2016,206(1-2),2-12","journal-title":"Mol Biochem Parasitol"},{"key":"ref=135","first-page":"3","volume":"1","author":"Mucke H.A.M.","year":"2015","unstructured":"Mucke H.A.M.; A new journal for the drug repurposing community. Drug Repurposing. Rescue and Repositioning 2015,1,3-4","journal-title":"Rescue and Repositioning"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1021\/ml300114c","volume":"3","author":"Aub\u00e9 J.","year":"2012","unstructured":"Aub\u00e9 J.; Drug repurposing and the medicinal chemist. ACS Med Chem Lett 2012,3(6),442-444","journal-title":"ACS Med Chem Lett"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1021\/jm5006463","volume":"57","author":"Anighoro A.","year":"2014","unstructured":"Anighoro A.; Bajorath J.; Rastelli G.; Polypharmacology: challenges and opportunities in drug discovery. J Med Chem 2014,57(19),7874-7887","journal-title":"J Med Chem"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/vhrm.2006.2.4.411","volume":"2","author":"Barnett C.F.","year":"2006","unstructured":"Barnett C.F.; Machado R.F.; Sildenafil in the treatment of pulmonary hypertension. Vasc Health Risk Manag 2006,2(4),411-422","journal-title":"Vasc Health Risk Manag"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.drudis.2013.11.005","volume":"19","author":"Jin G.","year":"2014","unstructured":"Jin G.; Wong S.T.C.; Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today 2014,19(5),637-644","journal-title":"Drug Discov Today"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2174\/138955751503150312120208","volume":"15","author":"Bellera C.L.","year":"2015","unstructured":"Bellera C.L.; Sbaraglini M.L.; Balcazar D.E.; Fraccaroli L.; Vanrell M.C.; Casassa A.F.; Labriola C.A.; Romano P.S.; Carrillo C.; Talevi A.; High-throughput drug repositioning for the discovery of new treatments for Chagas disease. Mini Rev Med Chem 2015,15(3),182-193","journal-title":"Mini Rev Med Chem"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.2174\/15680266113136660164","volume":"13","author":"Bolg\u00e1r B.","year":"2013","unstructured":"Bolg\u00e1r B.; Arany \u00c1.; Temesi G.; Balogh B.; Antal P.; M\u00e1tyus P.; Drug repositioning for treatment of movement disorders: from serendipity to rational discovery strategies. Curr Top Med Chem 2013,13(18),2337-2363","journal-title":"Curr Top Med Chem"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.bmcl.2016.03.103","volume":"26","author":"Klug D.M.","year":"2016","unstructured":"Klug D.M.; Gelb M.H.; Pollastri M.P.; Repurposing strategies for tropical disease drug discovery. Bioorg Med Chem Lett 2016,26(11),2569-2576","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.drudis.2016.06.021","volume":"21","author":"Ferreira L.G.","year":"2016","unstructured":"Ferreira L.G.; Andricopulo A.D.; Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective. Drug Discov Today 2016,21(10),1699-1710","journal-title":"Drug Discov Today"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.2174\/1568026616666160216154309","volume":"16","author":"Sbaraglini M.L.","year":"2016","unstructured":"Sbaraglini M.L.; Vanrell M.C.; Bellera C.L.; Benaim G.; Carrillo C.; Talevi A.; Romano P.S.; Neglected tropical protozoan diseases: drug repositioning as a rational option. Curr Top Med Chem 2016,16(19),2201-2222","journal-title":"Curr Top Med Chem"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.drudis.2011.02.016","volume":"16","author":"Ekins S.","year":"2011","unstructured":"Ekins S.; Williams A.J.; Krasowski M.D.; Freundlich J.S.; \n                        In silico repositioning of approved drugs for rare and neglected diseases. Drug Discov Today 2011,16(7-8),298-310","journal-title":"Drug Discov Today"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.drudis.2017.10.009","volume":"23","author":"Delavan B.","year":"2018","unstructured":"Delavan B.; Roberts R.; Huang R.; Bao W.; Tong W.; Liu Z.; Computational drug repositioning for rare diseases in the era of precision medicine. Drug Discov Today 2018,23(2),382-394","journal-title":"Drug Discov Today"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.tips.2013.03.004","volume":"34","author":"Novac N.","year":"2013","unstructured":"Novac N.; Challenges and opportunities of drug repositioning. Trends Pharmacol Sci 2013,34(5),267-272","journal-title":"Trends Pharmacol Sci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/acn3.76","volume":"1","author":"Shineman D.W.","year":"2014","unstructured":"Shineman D.W.; Alam J.; Anderson M.; Black S.E.; Carman A.J.; Cummings J.L.; Dacks P.A.; Dudley J.T.; Frail D.E.; Green A.; Lane R.F.; Lappin D.; Simuni T.; Stefanacci R.G.; Sherer T.; Fillit H.M.; Overcoming obstacles to repurposing for neurodegenerative disease. Ann Clin Transl Neurol 2014,1(7),512-518","journal-title":"Ann Clin Transl Neurol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1089\/adt.2015.29015.beddrrr","volume":"13","author":"Bloom B.E.","year":"2015","unstructured":"Bloom B.E.; Creating new economic incentives for repurposing generic drugs for unsolved diseases using social finance. Assay Drug Dev Technol 2015,13(10),606-611","journal-title":"Assay Drug Dev Technol"},{"key":"ref=150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000030","volume":"6","author":"Moran M.","year":"2009","unstructured":"Moran M.; Guzman J.; Ropars A.L.; McDonald A.; Jameson N.; Omune B.; Ryan S.; Wu L.; Neglected disease research and development: how much are we really spending? PLoS Med 2009,6(2)","journal-title":"PLoS Med"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.mito.2014.07.002","volume":"17","author":"Sahdeo S.","year":"2014","unstructured":"Sahdeo S.; Tomilov A.; Komachi K.; Iwahashi C.; Datta S.; Hughes O.; Hagerman P.; Cortopassi G.; High-throughput screening of FDA-approved drugs using oxygen biosensor plates reveals secondary mitofunctional effects. Mitochondrion 2014,17,116-125","journal-title":"Mitochondrion"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1128\/AAC.00680-13","volume":"57","author":"Siles S.A.","year":"2013","unstructured":"Siles S.A.; Srinivasan A.; Pierce C.G.; L\u00f3pez-Ribot J.L.; Ramasubramanian A.K.; High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors. Antimicrob Agents Chemother 2013,57(8),3681-3687","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ddtec.2017.04.001","volume":"23","author":"Ciallella J.R.","year":"2017","unstructured":"Ciallella J.R.; Reaume A.G.; \n                        In vivo phenotypic screening: clinical proof of concept for a drug repositioning approach. Drug Discov Today Technol 2017,23,45-52","journal-title":"Drug Discov Today Technol"},{"key":"ref=154","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135556","volume":"10","author":"Kaiser M.","year":"2015","unstructured":"Kaiser M.; M\u00e4ser P.; Tadoori L.P.; Ioset J.R.; Brun R.; Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning. PLoS One 2015,10(8)","journal-title":"PLoS One"},{"key":"ref=155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002977","volume":"8","author":"Planer J.D.","year":"2014","unstructured":"Planer J.D.; Hulverson M.A.; Arif J.A.; Ranade R.M.; Don R.; Buckner F.S.; Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi. PLoS Negl Trop Dis 2014,8(7)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1128\/AAC.01777-09","volume":"54","author":"Engel J.C.","year":"2010","unstructured":"Engel J.C.; Ang K.K.; Chen S.; Arkin M.R.; McKerrow J.H.; Doyle P.S.; Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas\u2019 disease. Antimicrob Agents Chemother 2010,54(8),3326-3334","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004584","volume":"10","author":"De Rycker M.","year":"2016","unstructured":"De Rycker M.; Thomas J.; Riley J.; Brough S.J.; Miles T.J.; Gray D.W.; Identification of trypanocidal activity for known clinical compounds using a new Trypanosoma cruzi hit-discovery screening cascade. PLoS Negl Trop Dis 2016,10(4)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ejmech.2015.01.065","volume":"93","author":"Bellera C.L.","year":"2015","unstructured":"Bellera C.L.; Balcazar D.E.; Vanrell M.C.; Casassa A.F.; Palestro P.H.; Gavernet L.; Labriola C.A.; G\u00e1lvez J.; Bruno-Blanch L.E.; Romano P.S.; Carrillo C.; Talevi A.; Computer-guided drug repurposing: identification of trypanocidal activity of clofazimine, benidipine and saquinavir. Eur J Med Chem 2015,93,338-348","journal-title":"Eur J Med Chem"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2149\/tmh.32.181","volume":"32","author":"Hirota K.","year":"2004","unstructured":"Hirota K.; Tsubouchi A.; Nakashima-Shimada J.; Nara T.; Aoki T.; Inhibition of Trypanosoma cruzi growth in mammalian cells by nimodipine, with low toxicity to host cells. Trop Med Health 2004,32,181-188","journal-title":"Trop Med Health"},{"key":"ref=160","first-page":"471","volume":"28","author":"Benaim B.","year":"2011","unstructured":"Benaim B.; Garcia C.R.; Targeting calcium homeostasis as the therapy of Chagas\u2019 disease and leishmaniasis - a review. Trop Biomed 2011,28(3),471-481","journal-title":"Trop Biomed"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.actatropica.2012.01.001","volume":"122","author":"Soares M.B.P.","year":"2012","unstructured":"Soares M.B.P.; Silva C.V.; Bastos T.M.; Guimar\u00e3es E.T.; Figueira C.P.; Smirlis D.; Azevedo W.F.; Jr. Anti-Trypanosoma cruzi activity of nicotinamide. Acta Trop 2012,122(2),224-229","journal-title":"Acta Trop"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1021\/ci400284v","volume":"53","author":"Bellera C.L.","year":"2013","unstructured":"Bellera C.L.; Balcazar D.E.; Alberca L.; Labriola C.A.; Talevi A.; Carrillo C.; Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effects. J Chem Inf Model 2013,53(9),2402-2408","journal-title":"J Chem Inf Model"},{"key":"ref=163","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/279618","volume":"2014","author":"Bellera C.L.","year":"2014","unstructured":"Bellera C.L.; Balcazar D.E.; Alberca L.; Labriola C.A.; Talevi A.; Carrillo C.; Identification of levothyroxine antichagasic activity through computer-aided drug repurposing. ScientificWorldJournal 2014,2014","journal-title":"ScientificWorldJournal"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1021\/jm050691f","volume":"49","author":"Benaim G.","year":"2006","unstructured":"Benaim G.; Sanders J.M.; Garcia-March\u00e1n Y.; Colina C.; Lira R.; Caldera A.R.; Payares G.; Sanoja C.; Burgos J.M.; Leon-Rossell A.; Concepcion J.L.; Schijman A.G.; Levin M.; Oldfield E.; Urbina J.A.; Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. J Med Chem 2006,49(3),892-899","journal-title":"J Med Chem"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrcardio.2012.108","volume":"9","author":"Benaim G.","year":"2012","unstructured":"Benaim G.; Paniz Mondolfi A.E.; The emerging role of amiodarone and dronedarone in Chagas disease. Nat Rev Cardiol 2012,9(10),605-609","journal-title":"Nat Rev Cardiol"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fcimb.2018.00173","volume":"8","author":"Alberca L.N.","year":"2018","unstructured":"Alberca L.N.; Sbaraglini M.L.; Morales J.F.; Dietrich R.; Ruiz M.D.; Pino MArt\u00ednez, A., Miranda, C. G., Fraccaroli, L.; Alba Soto, C.; Carrillo, C.; Palestro, P.H.; Talevi, A. Cascade ligand- and structure-based virtual screening to identify new trypanocidal compounds inhibiting putrescine uptake. Front Cell Infect Microbiol 2018,8,173","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijantimicag.2016.02.018","volume":"48","author":"Sbaraglini M.L.","year":"2016","unstructured":"Sbaraglini M.L.; Bellera C.L.; Fraccaroli L.; Larocca L.; Carrillo C.; Talevi A.; Alba Soto C.D.; Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease. Int J Antimicrob Agents 2016,48(1),91-95","journal-title":"Int J Antimicrob Agents"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/molecules22061015","volume":"22","author":"Palos I.","year":"2017","unstructured":"Palos I.; Lara-Ramirez E.E.; Lopez-Cedillo J.C.; Garcia-Perez C.; Kashif M.; Bocanegra-Garcia V.; Nogueda-Torres B.; Rivera G.; Repositioning FDA drugs as potential cruzain inhibitors from Trypanosoma cruzi: virtual screening, in vitro and in vivo studies. Molecules 2017,22(6),1015","journal-title":"Molecules"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ejmech.2017.03.063","volume":"132","author":"Lara-Ramirez E.E.","year":"2017","unstructured":"Lara-Ramirez E.E.; L\u00f3pez-Cedillo J.C.; Nogueda-Torres B.; Kashif M.; Garcia-Perez C.; Bocanegra-Garcia V.; Agusti R.; Uhrig M.L.; Rivera G.; An in vitro and in vivo evaluation of new potential trans-sialidase inhibitors of Trypanosoma cruzi predicted by a computational drug repositioning method. Eur J Med Chem 2017,132,249-261","journal-title":"Eur J Med Chem"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1021\/ci400155x","volume":"53","author":"Wu L.","year":"2013","unstructured":"Wu L.; Ai N.; Liu Y.; Wang Y.; Fan X.; Relating anatomical therapeutic indications by the ensemble similarity of drug sets. J Chem Inf Model 2013,53(8),2154-2160","journal-title":"J Chem Inf Model"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","volume":"25","author":"Keiser M.J.","year":"2007","unstructured":"Keiser M.J.; Roth B.L.; Armbruster B.N.; Ernsberger P.; Irwin J.J.; Shoichet B.K.; Relating protein pharmacology by ligand chemistry. Nat Biotechnol 2007,25(2),197-206","journal-title":"Nat Biotechnol"},{"key":"ref=172","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature08506","volume":"462","author":"Keiser M.J.","year":"2009","unstructured":"Keiser M.J.; Setola V.; Irwin J.J.; Laggner C.; Abbas A.I.; Hufeisen S.J.; Jensen N.H.; Kuijer M.B.; Matos R.C.; Tran T.B.; Whaley R.; Glennon R.A.; Hert J.; Thomas K.L.; Edwards D.D.; Shoichet B.K.; Roth B.L.; Predicting new molecular targets for known drugs. Nature 2009,462,175-181","journal-title":"Nature"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/B978-0-12-385863-4.00004-6","volume":"75","author":"Lepesheva G.I.","year":"2011","unstructured":"Lepesheva G.I.; Villalta F.; Waterman M.R.; Targeting Trypanosoma cruzi sterol 14\u03b1-demethylase (CYP51). Adv Parasitol 2011,75,65-87","journal-title":"Adv Parasitol"},{"key":"ref=174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065894","volume":"8","author":"Haupt V.J.","year":"2013","unstructured":"Haupt V.J.; Daminelli S.; Schroeder M.; Drug promiscuity in PDB: protein binding site similarity is key. PLoS One 2013,8(6)","journal-title":"PLoS One"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1021\/acs.jmedchem.6b00078","volume":"59","author":"Ehrt C.","year":"2016","unstructured":"Ehrt C.; Brinkjost T.; Koch O.; Impact of binding site comparisons on medicinal chemistry and rational molecular design. J Med Chem 2016,59(9),4121-4151","journal-title":"J Med Chem"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/bib\/bbr011","volume":"12","author":"Haupt V.J.","year":"2011","unstructured":"Haupt V.J.; Schroeder M.; Old friends in new guise: repositioning of known drugs with structural bioinformatics. Brief Bioinform 2011,12(4),312-326","journal-title":"Brief Bioinform"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.pbiomolbio.2014.05.006","volume":"116","author":"Salentin S.","year":"2014","unstructured":"Salentin S.; Haupt V.J.; Daminelli S.; Schroeder M.; Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment. Prog Biophys Mol Biol 2014,116(2-3),174-186","journal-title":"Prog Biophys Mol Biol"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1021\/acschembio.5b00683","volume":"10","author":"Barelier S.","year":"2015","unstructured":"Barelier S.; Sterling T.; O\u2019Meara M.J.; Shoichet B.K.; The recognition of identical ligands by unrelated proteins. ACS Chem Biol 2015,10(12),2772-2784","journal-title":"ACS Chem Biol"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"77","DOI":"10.21664\/2238-8869.2015v4i1.p77-84","volume":"4","author":"Rodrigues J.","year":"2015","unstructured":"Rodrigues J.; Alves N.R.; Da Silva F.G.; Cravo P.V.L.; Identification of new drugs against chagas disease through genomics and bioinformatics strategies. Fronteiras 2015,4,77-84","journal-title":"Fronteiras"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jbi.2012.07.003","volume":"45","author":"Cohen T.","year":"2012","unstructured":"Cohen T.; Widdows D.; Schvaneveldt R.W.; Davies P.; Rindflesch T.C.; Discovering discovery patterns with predication-based semantic indexing. J Biomed Inform 2012,45(6),1049-1065","journal-title":"J Biomed Inform"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.cell.2011.02.016","volume":"144","author":"Vidal M.","year":"2011","unstructured":"Vidal M.; Cusick M.E.; Barab\u00e1si A.L.; Interactome networks and human disease. Cell 2011,144(6),986-998","journal-title":"Cell"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","volume":"462","author":"Keiser M.J.","year":"2009","unstructured":"Keiser M.J.; Setola V.; Irwin J.J.; Laggner C.; Abbas A.I.; Hufeisen S.J.; Jensen N.H.; Kuijer M.B.; Matos R.C.; Tran T.B.; Whaley R.; Glennon R.A.; Hert J.; Thomas K.L.; Edwards D.D.; Shoichet B.K.; Roth B.L.; Predicting new molecular targets for known drugs. Nature 2009,462(7270),175-181","journal-title":"Nature"},{"key":"ref=183","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060618","volume":"8","author":"Emig D.","year":"2013","unstructured":"Emig D.; Ivliev A.; Pustovalova O.; Lancashire L.; Bureeva S.; Nikolsky Y.; Bessarabova M.; Drug target prediction and repositioning using an integrated network-based approach. PLoS One 2013,8(4)","journal-title":"PLoS One"},{"key":"ref=184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162407","volume":"11","author":"Vitali F.","year":"2016","unstructured":"Vitali F.; Cohen L.D.; Demartini A.; Amato A.; Eterno V.; Zambelli A.; Bellazzi R.; A network-based data integration approach to support drug repurposing and multi-target therapies in triple negative breast cancer. PLoS One 2016,11(9)","journal-title":"PLoS One"},{"key":"ref=185","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004300","volume":"10","author":"Berenstein A.J.","year":"2016","unstructured":"Berenstein A.J.; Magari\u00f1os M.P.; Chernomoretz A.; Ag\u00fcero F.; A multilayer network approach for guiding drug repositioning in neglected diseases. PLoS Negl Trop Dis 2016,10(1)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.drudis.2012.07.014","volume":"18","author":"Iorio F.","year":"2013","unstructured":"Iorio F.; Rittman T.; Ge H.; Menden M.; Saez-Rodr\u00edguez J.; Transcriptional data: a new gateway to drug repositioning? Drug Discov Today 2013,18(7-8),350-357","journal-title":"Drug Discov Today"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.2174\/1568026616666160927160912","volume":"17","author":"Sbaraglini M.L.","year":"2017","unstructured":"Sbaraglini M.L.; Talevi A.; Hybrid compounds as anti-infective agents. Curr Top Med Chem 2017,17(9),1080-1095","journal-title":"Curr Top Med Chem"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/jcb.25978","volume":"118","author":"Garc\u00eda-Huertas P.","year":"2017","unstructured":"Garc\u00eda-Huertas P.; Mej\u00eda-Jaramillo A.M.; Gonz\u00e1lez L.; Triana-Ch\u00e1vez O.; Transcriptome and functional genomics reveal the participation of adenine phosphoribosyltransferase in Trypanosoma cruzi resistance to benznidazole. J Cell Biochem 2017,118(7),1936-1945","journal-title":"J Cell Biochem"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biosystems.2015.11.010","volume":"141","author":"Margineanu D.G.","year":"2016","unstructured":"Margineanu D.G.; Neuropharmacology beyond reductionism - A likely prospect. Biosystems 2016,141,1-9","journal-title":"Biosystems"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","volume":"9","author":"Morphy R.","year":"2004","unstructured":"Morphy R.; Kay C.; Rankovic Z.; From magic bullets to designed multiple ligands. Drug Discov Today 2004,9(15),641-651","journal-title":"Drug Discov Today"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0035-9203(84)90184-6","volume":"78","author":"Hammond D.J.","year":"1984","unstructured":"Hammond D.J.; Cover B.; Gutteridge W.E.; A novel series of chemical structures active in vitro against the trypomastigote form of Trypanosoma cruzi. Trans R Soc Trop Med Hyg 1984,78(1),91-95","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0014-4894(85)80020-5","volume":"60","author":"Hammond D.J.","year":"1985","unstructured":"Hammond D.J.; Hogg J.; Gutteridge W.E.; Trypanosoma cruzi: possible control of parasite transmission by blood transfusion using amphiphilic cationic drugs. Exp Parasitol 1985,60(1),32-42","journal-title":"Exp Parasitol"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1042\/bj2860009","volume":"286","author":"Benson T.J.","year":"1992","unstructured":"Benson T.J.; McKie J.H.; Garforth J.; Borges A.; Fairlamb A.H.; Douglas K.T.; Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures. Biochem J 1992,286(Pt 1),9-11","journal-title":"Biochem J"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1021\/jm960814j","volume":"41","author":"Chan C.","year":"1998","unstructured":"Chan C.; Yin H.; Garforth J.; McKie J.H.; Jaouhari R.; Speers P.; Douglas K.T.; Rock P.J.; Yardley V.; Croft S.L.; Fairlamb A.H.; Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. J Med Chem 1998,41(2),148-156","journal-title":"J Med Chem"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.molbiopara.2008.03.006","volume":"160","author":"Buchholz K.","year":"2008","unstructured":"Buchholz K.; Comini M.A.; Wissenbach D.; Schirmer R.H.; Krauth-Siegel R.L.; Gromer S.; Cytotoxic interactions of methylene blue with trypanosomatid-specific disulfide reductases and their dithiol products. Mol Biochem Parasitol 2008,160(1),65-69","journal-title":"Mol Biochem Parasitol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0014-4894(89)90102-1","volume":"68","author":"Doyle P.S.","year":"1989","unstructured":"Doyle P.S.; Weinbach E.C.; The activity of tricyclic antidepressant drugs against Trypanosoma cruzi. Exp Parasitol 1989,68(2),230-234","journal-title":"Exp Parasitol"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1017\/S0031182013000103","volume":"140","author":"Fauro R.","year":"2013","unstructured":"Fauro R.; Lo Presti S.; Bazan C.; Baez A.; Strauss M.; Triquell F.; Cremonezzi D.; Negrete O.S.; Willhuber G.C.; Paglini-Oliva P.; Rivarola H.W.; Use of clomipramine as chemotherapy of the chronic phase of Chagas disease. Parasitology 2013,140(7),917-927","journal-title":"Parasitology"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1568006023337745","volume":"2","author":"Rivarola H.W.","year":"2002","unstructured":"Rivarola H.W.; Paglini-Oliva P.A.; Trypanosoma cruzi trypanothione reductase inhibitors: phenothiazines and related compounds modify experimental Chagas\u2019 disease evolution. Curr Drug Targets Cardiovasc Haematol Disord 2002,2(1),43-52","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0035-9203(01)90029-X","volume":"95","author":"Rivarola H.W.","year":"2001","unstructured":"Rivarola H.W.; Fern\u00e1ndez A.R.; Enders J.E.; Fretes R.; Gea S.; Paglini-Oliva P.; Effects of clomipramine on Trypanosoma cruzi infection in mice. Trans R Soc Trop Med Hyg 2001,95(5),529-533","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000090236","volume":"52","author":"Boda C.","year":"2006","unstructured":"Boda C.; Enanga B.; Courtioux B.; Breton J.C.; Bouteille B.; Trypanocidal activity of methylene blue. Evidence for in vitro efficacy and in vivo failure. Chemotherapy 2006,52(1),16-19","journal-title":"Chemotherapy"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.bmc.2015.01.018","volume":"23","author":"O\u2019Sullivan M.C.","year":"2015","unstructured":"O\u2019Sullivan M.C.; Durham T.B.; Valdes H.E.; Dauer K.L.; Karney N.J.; Forrestel A.C.; Bacchi C.J.; Baker J.F.; Dibenzosuberyl substituted polyamines and analogs of clomipramine as effective inhibitors of trypanothione reductase; molecular docking, and assessment of trypanocidal activities. Bioorg Med Chem 2015,23(5),996-1010","journal-title":"Bioorg Med Chem"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/14756369709029312","volume":"12","author":"Garforth J.","year":"1997","unstructured":"Garforth J.; Yin H.; McKie J.H.; Douglas K.T.; Fairlamb A.H.; Rational design of selective ligands for trypanothione reductase from Trypanosoma cruzi. Structural effects on the inhibition by dibenzazepines based on imipramine. J Enzyme Inhib 1997,12(3),161-173","journal-title":"J Enzyme Inhib"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0960-894X(00)00154-2","volume":"10","author":"Chibale K.","year":"2000","unstructured":"Chibale K.; Visser M.; Yardley V.; Croft S.L.; Fairlamb A.H.; Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against trypanothione reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani. Bioorg Med Chem Lett 2000,10(11),1147-1150","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1021\/jm000156+","volume":"43","author":"Khan M.O.","year":"2000","unstructured":"Khan M.O.; Austin S.E.; Chan C.; Yin H.; Marks D.; Vaghjiani S.N.; Kendrick H.; Yardley V.; Croft S.L.; Douglas K.T.; Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines. J Med Chem 2000,43(16),3148-3156","journal-title":"J Med Chem"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10822-016-9903-6","volume":"30","author":"Alberca L.N.","year":"2016","unstructured":"Alberca L.N.; Sbaraglini M.L.; Balcazar D.; Fraccaroli L.; Carrillo C.; Medeiros A.; Ben\u00edtez D.; Comini M.; Talevi A.; Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning. J Comput Aided Mol Des 2016,30(4),305-321","journal-title":"J Comput Aided Mol Des"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/00003088-199324030-00003","volume":"24","author":"van Harten J.","year":"1993","unstructured":"van Harten J.; Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet 1993,24(3),203-220","journal-title":"Clin Pharmacokinet"},{"key":"ref=207","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005472","volume":"11","author":"Reigada C.","year":"2017","unstructured":"Reigada C.; Valera-Vera E.A.; Say\u00e9 M.; Errasti A.E.; Avila C.C.; Miranda M.R.; Pereira C.A.; Trypanocidal effect of isotretinoin through the inhibition of polyamine and amino acid transporters in Trypanosoma cruzi. PLoS Negl Trop Dis 2017,11(3)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/BF00542224","volume":"24","author":"Colburn W.A.","year":"1983","unstructured":"Colburn W.A.; Vane F.M.; Shorter H.J.; Pharmacokinetics of isotretinoin and its major blood metabolite following a single oral dose to man. Eur J Clin Pharmacol 1983,24(5),689-694","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejmech.2018.02.006","volume":"149","author":"Dietrich R.C.","year":"2018","unstructured":"Dietrich R.C.; Alberca L.N.; Ruiz M.D.; Palestro P.H.; Carrillo C.; Talevi A.; Gavernet L.; Identification of cisapride as new inhibitor of putrescine uptake in Trypanosoma cruzi by combined ligand- and structure-based virtual screening. Eur J Med Chem 2018,149,22-29","journal-title":"Eur J Med Chem"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1016\/j.bmcl.2011.07.036","volume":"21","author":"Maccari G.","year":"2011","unstructured":"Maccari G.; Jaeger T.; Moraca F.; Biava M.; Floh\u00e9 L.; Botta M.; A fast virtual screening approach to identify structurally diverse inhibitors of trypanothione reductase. Bioorg Med Chem Lett 2011,21(18),5255-5258","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=211","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003773","volume":"9","author":"Beig M.","year":"2015","unstructured":"Beig M.; Oellien F.; Garoff L.; Noack S.; Krauth-Siegel R.L.; Selzer P.M.; Trypanothione reductase: a target protein for a combined in vitro and in silico screening approach. PLoS Negl Trop Dis 2015,9(6)","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/165704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T07:39:20Z","timestamp":1578555560000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/165704\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":211,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2019,12,13]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666180926151059","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}